ANKRD16
Ankyrin repeat domain-containing protein 16
Also known as: ANR16_HUMAN, DKFZP434N1511
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P6B7
- Gene
- ANKRD16
- Ensembl
- ENSG00000134461
- Chromosome
- 10
- Canonical length
- 361 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Predicted to be involved in tRNA modification. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>Q6P6B7|ANKRD16
1 MAQPGDPRRL CRLVQEGRLR ALKEELQAAG GCPGPAGDTL LHCAARHGHR DVLAYLAEAW
61 GMDIEATNRD YKRPLHEAAS MGHRDCVRYL LGRGAAVDCL KKADWTPLMM ACTRKNLGVI
121 QELVEHGANP LLKNKDGWNS FHIASREGDP LILQYLLTVC PGAWKTESKI RRTPLHTAAM
181 HGHLEAVKVL LKRCQYEPDY RDNCGVTALM DAIQCGHIDV ARLLLDEHGA CLSAEDSLGA
241 QALHRAAVTG QDEAIRFLVS ELGVDVDVRA TSTHLTALHY AAKEGHTSTI QTLLSLGADI
301 NSKDEKNRSA LHLACAGQHL ACAKFLLQSG LKDSEDITGT LAQQLPRRAD VLQGSGHSAM
361 TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 8.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 8.3 nTPM
- skin: 6.3 nTPM
- stomach: 6.3 nTPM
- cervix: 6.1 nTPM
- ovary: 5.9 nTPM
- fallopian tube: 5.6 nTPM
Single-cell type
- myonuclei: 60 nCPM
- retinal horizontal cells: 56 nCPM
- brain inhibitory neurons: 39 nCPM
- choroid plexus epithelial cells: 34 nCPM
- ependymal cells: 31 nCPM
- retinal amacrine cells: 31 nCPM
Immune cell
- plasmacytoid DC: 0.5 nTPM
- naive B-cell: 0.4 nTPM
- naive CD4 T-cell: 0.4 nTPM
- NK-cell: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- basophil: 0.2 nTPM
Brain region
- cerebral cortex: 20 nTPM
- basal ganglia: 15 nTPM
- white matter: 15 nTPM
- cerebellum: 15 nTPM
- pons: 15 nTPM
- amygdala: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANKRD16 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- AARS
- AARS1
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD16 as an antibody target. Whether an autoantibody or antibody against ANKRD16 could matter depends on whether native ANKRD16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD16 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANKRD16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...